HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (46) Citing Articles via Google Scholar Google Scholar Articles by D'Haese, P. C. Articles by De Broe, M. E. Search for Related Content PubMed PubMed Citation Articles by D'Haese, P. C. Articles by De Broe, M. E. Related Collections Nutrition Drug Monitoring and Toxicology Endocrinology and Metabolism

Aluminum, Iron, Lead, Cadmium, Copper, Zinc, Chromium, Magnesium, Strontium, and Calcium Content in Bone of End-Stage Renal Failure Patients

¹ Department of Nephrology-Hypertension, University of Antwerp, B-2650 Edegem, Belgium.

² UCLA School of Medicine, Los Angeles, CA 90095-1689.

³ Facultad de Ciencias Medicas, Asuncion, Paraguay.
^a Address correspondence to this author at: University of Antwerp, Department of Nephrology-Hypertension, p/a University Hospital Antwerp, Wilrijkstraat 10, B-2650 Edegem, Belgium. Fax 32-3-829-0100; e-mail snelders{at}uia.ua.ac.be

Background: Little is known about trace metal alterations in the bones of dialysis patients or whether particular types of renal osteodystrophy are associated with either increased or decreased skeletal concentrations of trace elements. Because these patients are at risk for alterations of trace elements as well as for morbidity from skeletal disorders, we measured trace elements in bone of patients with end-stage renal disease.

Methods: We analyzed bone biopsies of 100 end-stage renal failure patients enrolled in a hemodialysis program. The trace metal contents of bone biopsies with histological features of either osteomalacia, adynamic bone disease, mixed lesion, normal histology, or hyperparathyroidism were compared with each other and with the trace metal contents of bone of subjects with normal renal function. Trace metals were measured by atomic absorption spectrometry.

Results: The concentrations of aluminum, chromium, and cadmium were increased in bone of end-stage renal failure patients. Comparing the trace metal/calcium ratio, significantly higher values were found for the bone chromium/calcium, aluminum/calcium, zinc/calcium, magnesium/calcium, and strontium/calcium ratios. Among types of renal osteodystrophy, increased bone aluminum, lead, and strontium concentrations and strontium/calcium and aluminum/calcium ratios were found in dialysis patients with osteomalacia vs the other types of renal osteodystrophy considered as one group. Moreover, the concentrations of several trace elements in bone were significantly correlated with each other. Bone aluminum was correlated with the time on dialysis, whereas bone iron, aluminum, magnesium, and strontium tended to be associated with patient age. Bone trace metal concentrations did not depend on vitamin D intake nor on the patients' gender.

Conclusions: The concentration of several trace elements in bone of end-stage renal failure patients is disturbed, and some of the trace metals under study might share pathways of absorption, distribution, and accumulation. The clinical significance of the increased/decreased concentrations of several trace elements other than aluminum in bone of dialysis patients deserves further investigation.

The following articles in journals at HighWire Press have cited this article:

				G. B. Spasovski, A. Sikole, S. Gelev, J. Masin-Spasovska, T. Freemont, I. Webster, M. Gill, C. Jones, M. E. De Broe, and P. C. D'Haese Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2217 - 2224. [Abstract] [Full Text] [PDF]

				E. Guallar, E. K. Silbergeld, A. Navas-Acien, S. Malhotra, B. C. Astor, A. R. Sharrett, and B. S. Schwartz Confounding of the Relation between Homocysteine and Peripheral Arterial Disease by Lead, Cadmium, and Renal Function Am. J. Epidemiol., April 15, 2006; 163(8): 700 - 708. [Abstract] [Full Text] [PDF]

				P. C. D'Haese, F. Santacruz, M. E. De Broe, Y. Taur, F. Al-Tureihi, G. Wolf-Klein, and P. J. Meunier Postmenopausal Osteoporosis and Strontium Ranelate N. Engl. J. Med., May 6, 2004; 350(19): 2001 - 2003. [Full Text] [PDF]

				M. E. De Broe and P. C. D'Haese Strontium and osteomalacia in renal failure patients Nephrol. Dial. Transplant., January 1, 2003; 18(1): 215 - 216. [Full Text] [PDF]

				M. E. Cohen-Solal, F. Augry, Y. Mauras, C. Morieux, P. Allain, and M.-C. de Vernejoul Fluoride and strontium accumulation in bone does not correlate with osteoid tissue in dialysis patients Nephrol. Dial. Transplant., March 1, 2002; 17(3): 449 - 454. [Abstract] [Full Text] [PDF]

				C. N. Trueman and N. Tuross Trace Elements in Recent and Fossil Bone Apatite Reviews in Mineralogy and Geochemistry, January 1, 2002; 48(1): 489 - 521. [Full Text] [PDF]

				E. A. Ross, N. J. Szabo, and I. R. Tebbett Lead Content of Calcium Supplements JAMA, September 20, 2000; 284(11): 1425 - 1429. [Abstract] [Full Text] [PDF]